---Interlenticular opacification is the name coined by Dr. Apple for the formation of an opacifying membrane between piggyback IOLs, as seen here in this pair of explanted lenses. PHOTOGRAPH COURTESY ...
MARSHALLTOWN, Iowa — The Alcon AcrySof one-piece IOLs perform well, with fewer instances of pseudophakic dysphotopsia than the three-piece AcrySof, according to James Davison, MD. Dr. Davison reviewed ...
FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
PanOptix delivers outstanding patient satisfaction and freedom from glasses; Vivity has a proven exceptionally low rate of visual disturbances 2-8,**,Δ,§,^,‡ Alcon is committed to furthering ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Forty-four eyes of 33 patients underwent routine phacoemulsification cataract surgery with in-the-bag implantation of a toric AcrySof IOLs. Seven eyes were implanted with the SA60T3 IOL, 17 eyes were ...
Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...
We report a case of a patient who 4 weeks after uneventful phacoemulsification, underwent a dilated fundal examination, and subsequently developed pupil block. The intraocular lens was noted to be ...
Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results